ClinConnect ClinConnect Logo
Search / Trial NCT05747976

Genetic Disorders of Obesity Program Database

Launched by BAYLOR COLLEGE OF MEDICINE · Feb 27, 2023

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

ClinConnect Summary

The Genetic Disorders of Obesity Program Database is a clinical trial focused on understanding severe obesity in children that starts at an early age. The study aims to gather information about children who are struggling with obesity due to genetic factors. Researchers hope that by collecting this data, they can learn more about the causes and best ways to treat these conditions.

To be eligible for the trial, children must be at least 2 years old with a body mass index (BMI) greater than the 97th percentile, meaning they weigh more than 97% of children their age. For younger children under 2 years, they should have a weight-to-length ratio above the 95th percentile. There are no other specific exclusions, so many children with severe obesity may qualify. Participants in the study can expect to provide information about their health and may also undergo tests or assessments as part of the research. This study is currently recruiting participants of all genders, and it aims to improve our understanding of childhood obesity, which could lead to better treatments in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • For individuals 2 years and older, BMI \> 97 percentile
  • For individuals \< 2 years old, weight-to-length ratio \> 95th percentile
  • Exclusion Criteria:
  • No other exclusion criteria

About Baylor College Of Medicine

Baylor College of Medicine is a leading academic institution dedicated to advancing health through innovative research, education, and clinical care. Located in Houston, Texas, it is renowned for its commitment to excellence in medical education and translational research, fostering collaborations that bridge laboratory discoveries with clinical application. As a clinical trial sponsor, Baylor College of Medicine leverages its robust infrastructure, interdisciplinary expertise, and access to diverse patient populations to conduct cutting-edge clinical studies aimed at improving patient outcomes and enhancing therapeutic approaches across a wide range of medical conditions.

Locations

Houston, Texas, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials